Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: Inovio pharmaceuticals | Vintage Vibes

Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending Dec. 31,

MarketBeat · May 25

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022

Upgrades

Benzinga · Nov 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Benzinga · May 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Inovio Pharmaceuticals: Q1 Earnings Insights

Inovio Pharmaceuticals (NASDAQ:INO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · May 10, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.

Benzinga · May 10, 2022

Inovio Pharmaceuticals: Q4 Earnings Insights

Inovio Pharmaceuticals (NASDAQ:INO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 1, 2022

Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals

Following the recent pullback in Inovio Pharmaceuticals Inc.’s (NASDAQ: INO) shares, the stock valuation seems to have been stripped of most of the remaining COVID-19 value, according to BofA Securities.

Benzinga · Jan 21, 2022

Read news from The Economist, FT, and more,
with one subscription

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.